Key facts
- It has raised $42.9M; the latest was Later Stage VC ($29.0M) in Mar 2026.
- Notable investors include Guangdong Technology Financial Group, Zhuhai High-tech Financial Investment, Guangdong Yuecai Venture Capital, Zhongshan Finance Investment, TuringPE — 11 tracked in total.
- Status: Privately Held (backing).
Investors
11+- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Conmind Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Conmind Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Conmind Medical
Developer of medical instruments designed for cardiovascular diseases. The company offers microcatheter, micro guide wires, distal embolic protection systems, intracranial coil embolization systems, and interventional mitral valve chordal repair systems, which can be used in the fields of heart, cerebrovascular and pan-vascular, thereby providing patients with safe, effective, innovative and reliable neurological intervention and cardiac interventional diagnosis and treatment equipment.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2020
- Employees
- 200
- Website
- conmindmed.com/
- Ownership
- Privately Held (backing)
Conmind Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Conmind Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Conmind Medical in its N-PORT filings yet. We sweep new filings monthly.